Harvard
More adults with type 2 diabetes now using GLP-1s instead of DPP-IV inhibitors
Of adults with type 2 diabetes who used an incretin-based medication, the majority received an injectable GLP-1 receptor agonist in the first quarter of 2022, according to study findings.
AI tool helps identify pancreatic cancer risk up to 3 years before diagnosis
Researchers at Harvard Medical School and University of Copenhagen developed an artificial intelligence tool with the potential to identify people at greatest risk for pancreatic cancer up to 3 years before diagnosis.
Mezigdomide-dexamethasone combination active in heavily pretreated multiple myeloma
The combination of mezigdomide and dexamethasone exhibited activity among patients with heavily pretreated multiple myeloma, according to study results published in The New England Journal of Medicine.
Growth hormone lowers liver fat for adults with obesity, steatotic liver disease
Adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease had a more than 5% reduction in liver fat at 6 months with growth hormone therapy, according to findings from a randomized controlled trial.
Sleep apnea hypoxic burden predicts cardiovascular disease, mortality
Obstructive sleep apnea-related increases in hypoxic and ventilatory burdens heightened the risk for cardiovascular disease, according to results published in American Journal of Respiratory and Critical Care Medicine.
Alcohol-related deaths rising in US, particularly among women
Men continue to be more likely to die from alcohol than women; however, women have seen a greater increase in alcohol-related mortality rates in recent years, highlighting the need for evidence-based interventions, according to researchers.
Image-guided adaptive prostate radiation therapy reduces risk for short-term toxicities
Magnetic resonance-guided daily adaptive stereotactic body radiotherapy appeared associated with a reduction in acute toxicity compared with a more common technique for men with prostate cancer, according to data published in Cancer.
Study reveals why people with blood group A are ‘slightly more likely’ to acquire COVID-19
Researchers have identified a direct correlation between blood group A and increased risk for COVID-19 infection, according to study results published in Blood.
VIDEO: Epcoritamab plus R2 ‘showed potent antitumor activity’ in follicular lymphoma
CHICAGO - In this video, Reid Merryman, MD, discusses updates on a trial testing the combination of epcoritamab, rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma.
Everyday interaction makes ‘miracle’ happen in cancer care
Editor’s note: This is the last in a series of five stories from ASCO Voices, a session during ASCO Annual Meeting focused on the human side of oncology.